Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 18.75
+0.62 (3.42%)
Jun 23, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 3.59 billion as of June 22, 2026. Its market cap has decreased by -56.29% in one year.
Market Cap
3.59B
Enterprise Value
4.37B
Revenue
1.46B
Ranking
n/a
PE Ratio
31.96
Stock Price
18.75
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 3.59B, a decrease of -55.98%. That is a compound annual growth rate of -13.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.62B | -42.32% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 3.86B |
| Assure Tech (Hangzhou) | 3.83B |
| ChemPartner PharmaTech | 3.81B |
| Beijing Bohui Innovation Biotechnology Group | 3.64B |
| Hinova Pharmaceuticals | 3.52B |
| Hefei Lifeon Pharmaceutical | 3.50B |
| Shanghai Obio Technology (Group) Corp. | 3.50B |
| Shanghai Shen Lian Biomedical | 3.46B |